TrialCritical care (London, England)2020

(1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial.

Gennaro De Pascale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.